JILL MATNEY: Open Payments
NPI 1962483339 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 30 payments from 7 companies in 2025. Trend: 2023 $419 · 2024 $726 · 2025 $683
Food & beverage: $670Consulting: $13
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $298 |
| AstraZeneca Pharmaceuticals LP | 9 | $198 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Genentech USA, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| ADMA BioManufacturing LLC | 1 | $13 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, NUCALA, Xolair, DAWNZERA, Rhapsido, FASENRA.
Industry payments across VA — which companies pay providers there.
